Melatonin does not reduce mortality in adult hospitalized patients with COVID-19: a multicenter retrospective observational study

Melatonin does not reduce mortality in adult hospitalized patients with COVID-19: a multicenter retrospective observational study

In this multicenter retrospective observational study involving 58 562 adult patients hospitalized for COVID-19, melatonin use (N = 272) at a mean daily dose of 2.6 mg was not associated with reduced mortality.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of travel medicine 2022-05, Vol.29 (3)
Hauptverfasser: Sánchez-Rico, Marina, de la Muela, Pedro, Herrera-Morueco, Juan J, Geoffroy, Pierre A, Limosin, Frédéric, Hoertel, Nicolas
Format: Artikel
Sprache:eng
Schlagworte:
Anxiety
Clinical trials
Consortia
Coronaviruses
COVID-19
Data warehouses
Dementia
Drug dosages
Hospitalization
Hospitals
Human health and pathology
Insomnia
Life Sciences
Medical research
Melatonin
Mortality
Neurosciences
Obesity
Observational studies
Research Letter
Risk factors
Severe acute respiratory syndrome coronavirus 2
Sleep
Travel medicine
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In this multicenter retrospective observational study involving 58 562 adult patients hospitalized for COVID-19, melatonin use (N = 272) at a mean daily dose of 2.6 mg was not associated with reduced mortality.
ISSN:1195-1982
1708-8305
DOI:10.1093/jtm/taab195